Adial Pharmaceuticals, Inc. Deferred Income Tax Expense (Benefit)
Adial Pharmaceuticals, Inc. (ADIL) reported Deferred Income Tax Expense (Benefit) of -$502 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2023-03-30
- Adial Pharmaceuticals, Inc. deferred income tax expense (benefit) for the quarter ending 2021-12-31 was -$101.03K.
- Adial Pharmaceuticals, Inc. deferred income tax expense (benefit) for the quarter ending 2021-09-30 was $0.00.
- Adial Pharmaceuticals, Inc. deferred income tax expense (benefit) for the quarter ending 2021-06-30 was $0.00.
- Adial Pharmaceuticals, Inc. deferred income tax expense (benefit) for the quarter ending 2021-03-31 was $6.95K.
- Adial Pharmaceuticals, Inc. deferred income tax expense (benefit) for fiscal 2022 was -$502.00.
- Adial Pharmaceuticals, Inc. deferred income tax expense (benefit) for fiscal 2021 was -$94.08K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$502.00 10-K · filed 2023-03-30 | |||
| 2021-12-31 | -$101.03K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$101.03K derived: sum of 2 quarters · filed 2023-03-30 | -$101.03K derived: sum of 3 quarters · filed 2023-03-30 | -$94.08K 10-K · filed 2023-03-30 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $6.95K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $6.95K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $6.95K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |